Avantor (AVTR) Stock Price, News & Analysis

Company Overview

Avantor, Inc. (NYSE: AVTR) is a global provider of products and services used in the life sciences, healthcare and advanced technology industries. The company supports research, drug discovery, biopharmaceutical production, clinical and diagnostic activities, and other laboratory-based applications.

Its offerings include laboratory chemicals and reagents, consumables, equipment, instruments, production materials and related services. Avantor also provides supply-chain, procurement and other technical solutions designed to help customers manage laboratory and manufacturing operations.

Avantor serves customers across pharmaceutical and biopharmaceutical companies, healthcare providers, academic and government institutions, medical laboratories and industrial businesses. The company operates internationally, with operations and customers spanning North America, Europe, Asia and other global markets.

The business includes the VWR organization, which Avantor acquired in 2017 to expand its laboratory products, distribution capabilities and geographic reach. Avantor is headquartered in Radnor, Pennsylvania.

Key Stats

• Today's Range: $14.72 to $15.14
• 50-Day Range: $10.67 to $15.85
• 52-Week Range: $7.26 to $16.05
• Volume: 6.99 million shs
• Average Volume: 10.24 million shs
• Market Capitalization: $10.01 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.47
• Consensus Rating: Hold

Avantor Stock Analysis - MarketRank™

Avantor scored higher than 28% of companies evaluated by MarketBeat, and ranked 763rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Avantor has received a consensus rating of Hold. The company's average rating score is 2.06, and is based on no strong buy ratings, 2 buy ratings, 15 hold ratings, and 1 sell rating.

Downside Risk

Avantor has a consensus price target of $12.47, representing about 16.2% downside from its current price of $14.89.

Amount of Analyst Coverage

Avantor has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 7.41%

Earnings Growth

Earnings for Avantor are expected to grow by 7.41% in the coming year, from $0.81 to $0.87 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Avantor is -17.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Avantor is -17.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Avantor has a PEG Ratio of 11.40. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Avantor has a P/B Ratio of 1.82. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.44% of the float of Avantor has been sold short.

Short Interest Ratio / Days to Cover

Avantor has a short interest ratio ("days to cover") of 8.66.

Change versus previous month

Short interest in Avantor has recently decreased by 3.79%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Avantor does not currently pay a dividend.

Dividend Growth

Avantor does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.21

News Sentiment

Avantor has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Avantor this week, compared to 9 articles on an average week.

Search Interest

Only 1 people have searched for AVTR on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Avantor insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.28% of the stock of Avantor is held by insiders.

Percentage Held by Institutions

95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 9/23/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:AVTR
• CIK: 1722482
• Web: www.avantorsciences.com
• Phone: (610) 386-1700
• Fax: N/A
• Employees: 13,500
• Year Founded: 1904

Price Target and Rating

• Average Price Target for Avantor: $12.47
• High Price Target: $16.00
• Low Price Target: $7.00
• Potential Upside/Downside: -16.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.06
• Research Coverage: 18 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.84)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 18.35
• P/E Growth: 11.4
• Net Income: -$530.20 million
• Net Margins: -8.81%
• Pretax Margin: -7.19%
• Return on Equity: 9.92%
• Return on Assets: 4.75%

Debt

• Debt-to-Equity Ratio: 0.65
• Current Ratio: 1.78
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $6.55 billion
• Price / Sales: 1.53
• Cash Flow: $1.49 per share
• Price / Cash Flow: 9.97
• Book Value: $8.16 per share
• Price / Book: 1.82

Miscellaneous

• Outstanding Shares: 676,360,000
• Free Float: 674,465,000
• Market Cap: $10.05 billion
• Optionable: Optionable
• Beta: 0.89